Is Adrenal Cancer Curable With Surgery Alone?

Complete surgical resection with clear margins is what determines the answer, not surgery in general. When the tumour is early, localised, and removed with clean margins, surgery alone can cure it. Recurrence is the real obstacle, adrenal cancer returns often enough, even after a technically clean operation, that higher risk cases need adjuvant mitotane added afterward to hold that cure in place. Surgery is the essential step. Whether it’s the only step depends on the resection and the risk profile.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Complete resection with clear margins is the only treatment that can cure adrenal cancer, and for a small, early tumour removed cleanly, surgery alone sometimes does the job. But this cancer has a real tendency to recur, even after a technically perfect operation. For higher grade or higher stage disease, adjuvant mitotane meaningfully lowers that recurrence risk. Surgery earns the chance at cure. Adjuvant treatment often protects it.”

Complete resection is the foundation of any cure, but its reach has real limits.

• The only curative step : No treatment cures adrenal cancer without removing the tumour completely. Surgery is the non negotiable starting point.
• Clear margins matter : An R0 resection, with no cancer at the cut edge, gives the best chance. Incomplete removal rarely offers lasting cure.
• Early disease does best : Small, localised tumours caught before spread have the strongest odds of surgery alone being sufficient.
• Recurrence remains common : Even after a clean resection, this cancer returns in a meaningful proportion of cases, which is the central limitation.

Getting that first operation right is the core of proper adrenal tumor treatment, since nothing that follows can fix an incomplete resection.

For a real portion of patients, the operation is the start of treatment, not the end of it.

• Higher grade tumours : A more aggressive tumour under the microscope carries higher recurrence risk, which is when adjuvant treatment earns its place.
• Larger or higher stage disease : Bigger tumours or ones with wider local spread at surgery recur more often, tilting the case toward adjuvant mitotane.
• Adjuvant mitotane : This drug, taken after surgery, lowers the chance of recurrence in higher risk cases, protecting the result the operation achieved.
• Ongoing surveillance : Regular imaging after surgery catches any recurrence early, when it’s still most treatable.

Understanding these growths from the outset, covered in our adrenal tumor overview, helps explain why adrenal cancer specifically needs this layered approach.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats adrenal cancer with the goal of a complete, margin negative resection from the outset, since a compromised first operation limits every option afterward. The approach means working alongside medical oncology for adjuvant treatment decisions, treating surgery as the essential first step rather than the entire answer.

Adrenal cancer punishes an incomplete first operation more than most cancers do. A resection that leaves cancer behind, or ruptures the tumour during removal, closes the door on cure regardless of what treatment follows. Getting that first surgery right, then adding adjuvant therapy where the risk profile calls for it, is what gives this difficult cancer its best realistic chance at lasting control.

References

1. Outcomes after resection of adrenocortical carcinoma — National Library of Medicine
2. Adjuvant mitotane therapy after adrenocortical carcinoma resection — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.